Nexalin Technology, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:NXL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Quarterly Annual

Total assets 2.9 M6.56 M5.13 M4.64 M3.69 M3 M Total liabilities 574.74 K600.58 K357.52 K887.33 K808.36 K1.48 M Total equity 2.33 M5.96 M4.77 M3.75 M2.89 M1.52 M Total liabilities & shareholders' equities 2.9 M6.56 M5.13 M4.64 M3.69 M3 M Total debt —————— Net debt ——————

News

EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device - Nexali

EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Nexalin Technology (NASDAQ:NXL)

Nuix 1H26 presentation: Neo platform surges 148%, cash flow turns positive

Earnings call transcript: Nuix Ltd reports strong H1 2026 growth amid Neo platform expansion

Nexalin Technology stock rises after launching AI-powered virtual clinic

EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Nexalin Technology (NASDAQ:NXL)

Nexalin reports brain imaging studies validate its neurostimulation tech

Nexalin receives Nasdaq minimum bid price deficiency notice

Nexalin advances Alzheimer’s device after FDA meeting

Nexalin Technology earnings missed by $0.01, revenue fell short of estimates

Nexalin signs exclusive distribution deal for neurostimulation device in Israel

FDA accepts Nexalin’s submission for Alzheimer’s treatment device